SMS Lifesciences India Limited (SMSLIFE.NS)
INR 1179.0
(-0.08%)
INR 1179.0
(-0.08%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 331.45 Million INR | -29.89% |
| 2022 | 472.75 Million INR | 12.07% |
| 2021 | 421.85 Million INR | 6.48% |
| 2020 | 396.18 Million INR | 5.25% |
| 2019 | 376.42 Million INR | 38.37% |
| 2018 | 272.04 Million INR | 79.09% |
| 2017 | 151.9 Million INR | -5.8% |
| 2016 | 161.25 Million INR | -30.75% |
| 2015 | 232.84 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 331.45 Million INR | -29.89% |
| 2023 Q4 | 331.45 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 385.16 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 571.6 Million INR | 0.0% |
| 2022 FY | 472.75 Million INR | 12.07% |
| 2022 Q4 | 472.75 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q2 | 421.2 Million INR | 0.0% |
| 2021 Q4 | 421.85 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 421.85 Million INR | 6.48% |
| 2020 Q2 | 436.85 Million INR | 0.0% |
| 2020 FY | 396.18 Million INR | 5.25% |
| 2020 Q4 | 396.18 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 290.8 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 376.42 Million INR | 38.37% |
| 2019 Q4 | 376.42 Million INR | 0.0% |
| 2018 FY | 272.04 Million INR | 79.09% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 272.04 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 121.23 Million INR | 0.0% |
| 2017 FY | 151.9 Million INR | -5.8% |
| 2017 Q2 | 132.98 Million INR | 0.0% |
| 2017 Q4 | 151.9 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 FY | 161.25 Million INR | -30.75% |
| 2016 Q4 | 161.25 Million INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 FY | 232.84 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Biocon Limited | 129.32 Billion INR | 99.744% |
| Blue Jet Healthcare Limited | 3.79 Million INR | -8645.383% |
| Concord Biotech Limited | 18.87 Million INR | -1656.492% |
| Dishman Carbogen Amcis Limited | 2.45 Billion INR | 86.505% |
| Jubilant Ingrevia Limited | 4.25 Billion INR | 92.212% |
| Lyka Labs Limited | 429.06 Million INR | 22.751% |
| Panacea Biotec Limited | 209.9 Million INR | -57.909% |
| Piramal Pharma Limited | 24.83 Billion INR | 98.666% |
| Supriya Lifescience Limited | 50.2 Million INR | -560.259% |
| Syngene International Limited | 1 Billion INR | 66.855% |
| TAKE Solutions Limited | 7.5 Million INR | -4319.333% |
| Zota Health Care Limited | 631.64 Million INR | 47.526% |